Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Langmuir. 2017 Jul 19;33(30):7529–7537. doi: 10.1021/acs.langmuir.7b01132

Figure 1.

Figure 1

Molecular structures of β-hematin inhibitors used in this study. (1) 4-Aminoquinoline short-chain CQ analogues and (2) non-quinoline benzamide derivatives. See Table 2 for R1, R2, Ar and X substituents.